![]() ![]() ![]() FULL PRESCRIBING INFORMATION: CONTENTS * 1 INDICATIONS AND USAGE 1.1 Hypertension 1.2 Angina Pectoris 1.3 Heart Failure 2 DOSAGE AND ADMINISTRATION 2.1 Hypertension 2.2 Angina Pectoris 2.3 Heart Failure 2.4 Administration 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 5 WARNINGS AND PRECAUTIONS 5.1 Abrupt Cessation of Therapy 5.2 Heart Failure 5.3 Bronchospastic Disease 5.4 Bradycardia 5.5 Pheochromocytoma 5.6 Major Surgery 5.7 Hypoglycemia 5.8 Thyrotoxicosis 5.9 Peripheral Vascular Disease 5.10 Anaphylactic Reaction 6 ADVERSE REACTIONS 6.1 Clinical Trials Experience 6.2 Post-Marketing Experience 7 DRUG INTERACTIONS 7.1 Catecholamine Depleting Drugs 7.2 CYP2D6 Inhibitors 7.3 Digitalis, Clonidine, and Calcium Channel Blockers 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Lactation 8.3 Females and Males of Reproductive Potential 8.4 Pediatric Use 8.5 Geriatric Use 8.6 Hepatic Impairment 8.7 Renal Impairment 10 OVERDOSAGE 11 DESCRIPTION 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action 12.2 Pharmacodynamics 12.3 Pharmacokinetics 12.5 Pharmacogenomics 13 NONCLINICAL TOXICOLOGY 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility 14 CLINICAL STUDIES 14.1 Hypertension 14.2 Angina Pectoris 14.3 Heart Failure 16 HOW SUPPLIED/STORAGE AND HANDLING 17 PATIENT COUNSELING INFORMATION * Sections or subsections omitted from the full prescribing information are not listed. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |